Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Identification of gene markers associated with metastasis in clear cell renal cell carcinoma.

Yang H, Huo P, Hu G, Wei B, Kong D, Li H.

Oncol Lett. 2017 Jun;13(6):4755-4761. doi: 10.3892/ol.2017.6084. Epub 2017 Apr 24.

2.

Metadherin regulates actin cytoskeletal remodeling and enhances human gastric cancer metastasis via epithelial-mesenchymal transition.

Du Y, Jiang B, Song S, Pei G, Ni X, Wu J, Wang S, Wang Z, Yu J.

Int J Oncol. 2017 Jul;51(1):63-74. doi: 10.3892/ijo.2017.4002. Epub 2017 May 17.

3.

YAP modulates TGF-β1-induced simultaneous apoptosis and EMT through upregulation of the EGF receptor.

Liu Y, He K, Hu Y, Guo X, Wang D, Shi W, Li J, Song J.

Sci Rep. 2017 Apr 20;7:45523. doi: 10.1038/srep45523.

4.

Clinicopathological features for predicting central and lateral lymph node metastasis in papillary thyroid microcarcinoma: Analysis of 66 cases that underwent central and lateral lymph node dissection.

Tao Y, Wang C, Li L, Xing H, Bai Y, Han B, Liu Z, Yang X, Zhu S.

Mol Clin Oncol. 2017 Jan;6(1):49-55. doi: 10.3892/mco.2016.1085. Epub 2016 Nov 18.

5.

Direct Regulation of Alternative Splicing by SMAD3 through PCBP1 Is Essential to the Tumor-Promoting Role of TGF-β.

Tripathi V, Sixt KM, Gao S, Xu X, Huang J, Weigert R, Zhou M, Zhang YE.

Mol Cell. 2016 Nov 3;64(3):549-564. doi: 10.1016/j.molcel.2016.09.013. Epub 2016 Oct 13.

PMID:
27746021
6.

Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells.

Yoh KE, Regunath K, Guzman A, Lee SM, Pfister NT, Akanni O, Kaufman LJ, Prives C, Prywes R.

Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):E6107-E6116. Epub 2016 Sep 28.

7.

AKT-ions with a TWIST between EMT and MET.

Tang H, Massi D, Hemmings BA, Mandalà M, Hu Z, Wicki A, Xue G.

Oncotarget. 2016 Sep 20;7(38):62767-62777. doi: 10.18632/oncotarget.11232. Review.

8.

TGF-β1 stimulates migration of type II endometrial cancer cells by down-regulating PTEN via activation of SMAD and ERK1/2 signaling pathways.

Xiong S, Cheng JC, Klausen C, Zhao J, Leung PC.

Oncotarget. 2016 Sep 20;7(38):61262-61272. doi: 10.18632/oncotarget.11311.

9.

Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways.

Zamanian M, Qader Hamadneh LA, Veerakumarasivam A, Abdul Rahman S, Shohaimi S, Rosli R.

Cancer Cell Int. 2016 Jul 13;16:56. doi: 10.1186/s12935-016-0329-y. eCollection 2016.

10.

Potential signaling pathway involved in sphingosine-1-phosphate-induced epithelial-mesenchymal transition in cancer.

Zeng YE, Yao XH, Yan ZP, Liu JX, Liu XH.

Oncol Lett. 2016 Jul;12(1):379-382. Epub 2016 Jun 1.

11.

The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis.

Lebrun JJ.

ISRN Mol Biol. 2012 Dec 24;2012:381428. doi: 10.5402/2012/381428. eCollection 2012. Review.

12.

Simvastatin blocks TGF-β1-induced epithelial-mesenchymal transition in human prostate cancer cells.

Xie F, Liu J, Li C, Zhao Y.

Oncol Lett. 2016 May;11(5):3377-3383. Epub 2016 Apr 1.

13.

A20 inhibits the motility of HCC cells induced by TNF-α.

Wang X, Ma C, Zong Z, Xiao Y, Li N, Guo C, Zhang L, Shi Y.

Oncotarget. 2016 Mar 22;7(12):14742-54. doi: 10.18632/oncotarget.7521.

14.

Microenvironmental interactions and expression of molecular markers associated with epithelial-to-mesenchymal transition in colorectal carcinoma.

Lee SJ, Yang CS, Kim DD, Kang YN, Kwak SG, Park JB, Cho CH, Park KK.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):14270-82. eCollection 2015.

15.

High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.

Shukla P, Vogl C, Wallner B, Rigler D, Müller M, Macho-Maschler S.

BMC Genomics. 2015 Nov 16;16:944. doi: 10.1186/s12864-015-2036-9.

16.

Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer.

Yang M, Huang CZ.

World J Gastroenterol. 2015 Nov 7;21(41):11673-9. doi: 10.3748/wjg.v21.i41.11673. Review.

17.

Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.

Sahin IH, Iacobuzio-Donahue CA, O'Reilly EM.

Expert Opin Ther Targets. 2016;20(3):341-59. doi: 10.1517/14728222.2016.1094057. Epub 2015 Oct 6. Review.

18.

DA-Raf-Mediated Suppression of the Ras--ERK Pathway Is Essential for TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells.

Watanabe-Takano H, Takano K, Hatano M, Tokuhisa T, Endo T.

PLoS One. 2015 May 21;10(5):e0127888. doi: 10.1371/journal.pone.0127888. eCollection 2015.

19.

Epithelial Mesenchymal Transition: a double-edged sword.

Barriere G, Fici P, Gallerani G, Fabbri F, Rigaud M.

Clin Transl Med. 2015 Apr 14;4:14. doi: 10.1186/s40169-015-0055-4. eCollection 2015.

20.

MTH1 expression is required for effective transformation by oncogenic HRAS.

Giribaldi MG, Munoz A, Halvorsen K, Patel A, Rai P.

Oncotarget. 2015 May 10;6(13):11519-29.

Supplemental Content

Support Center